Healthcare Realty Trust (NYSE:HR) Stock, Quote.Headers.trade-ideas

Healthcare Realty Trust

Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company considers merger and acquisition investment as a component of its operational growth strategy. It works with developers that have strong ties to a local health system and physicians. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.

Wall Street

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

Core Scientific, Inc. - Class A Common Stock

CORZ

WEST

Executives Buying Core Scientific And 2 Other Stocks

homes-ai4

Equities

Large Cap

Macro Economic Events

Mid Cap

REIT

Sector ETFs

Small Cap

Econ #s

Economics

Federal Reserve

ETFs

Real Estate

CBRE

RDFN

iShares FTSE NAREIT Residential PLUS Capped Index Fund

SBRA

XLRE

Good news for US homebuyers as mortgage rates drop to lowest level since May 2023. Despite this, mortgage applications dip as buyers wait for Fed&#39;s future policy direction. Real estate sector up.

30-Year Mortgage Rates Hit 15-Month Low, But Applications Pull Back After Recent Spikes: Real Estate Stocks React Wednesday (CORRECTED)

Movers

Short Ideas

EXPI

Top 3 Real Estate Stocks That May Implode In Q2

Healthcare Realty Trust Incorporated Common Stock

Healthcare Realty Trust Inc

HEAR ATLAST HOLDINGS INC by Hear AtLast Holdings, Inc.

Hear AtLast Holdings Inc

Hera SpA

H&R Block Inc

HARBOR BANKSHARES CORP by Harbor Bankshares Corporation

Harbor Bankshares Corp

HARBOR DIVERSIFIED INC by Harbor Diversified, Inc.

Harbor Diversified Inc

HERSHEY CREAMERY CO by Hershey Creamery Co.

Hershey Creamery Co

Hurricane Energy PLC

Huarui International New Material Ltd

Here Media Inc

Stans Energy Corp

Harfang Exploration Inc

HERITAGE NOLA BANCORP INC by Heritage Nola Bancorp Inc

Heritage NOLA Bancorp Inc

HARGREAVES LANSDOWN ORD by Hargreaves Lansdown PLC

Hargreaves Lansdown PLC

Hargreaves Lansdown PLC ADR

HARVARD APPRATS REG TCH by Harvard Apparatus Regenerative Technology Inc.

Harvard Apparatus Regenerative Technology Inc

Herc Holdings Inc

Horiba Ltd

REVOLUTION CO LTD by REVOLUTION CO LTD.

Hormel Foods Corp

High Roller Technologies, Inc

Harmony Biosciences Holdings, Inc. - Common Stock

Harmony Biosciences Holdings Inc

Hydro One Ltd

HRnetGroup Ltd

HIROSE ELECTRIC UNSP/ADR by Hirose Electric

Hirose Electric Co Ltd

HIROGIN HOLDINGS INC by Hirogin Holdings Inc.

Hirogin Holdings Inc

Harrow Inc

Harrow, Inc. - 8.625% senior notes due 2026

Harrow, Inc. - 11.875% Senior Notes due 2027

HAIER SMART HOME CO LTD by HAIER SMART HOME CO LTD.

Haier Smart Home Co Ltd

HORRISON RESOURCES INC by Horrison Resources Inc.

Horrison Resources Inc

HARVEST OIL & GAS CORP by Harvest Oil & Gas Corp.

Harvest Oil & Gas Corp

HIRERIGHT HLDGS CORP COM

Heritage Insurance Holdings, Inc. Common Stock

Heritage Insurance Holdings Inc

Tema GLP-1, Obesity & Cardiometabolic ETF

Heart Tronics Inc

Heron Therapeutics Inc

H&R Real Estate Investment Trust Stapled Units Cons of 1 H&R REIT Ut ' 1 H&R Finance Trust Ut

H&R Real Estate Investment Trust

Harvia PLC

Hanryu Holdings Inc

HORIZON CONST DEV LTD by HORIZON CONSTRUCTION DEVELOPMENT LTD.

Horizon Construction Development Ltd

HORIZON MINERALS LTD by HORIZON MINERALS LTD.

Horizon Minerals Ltd

Horizon Technology Finance Corporation - Common Stock

Horizon Technology Finance Corp

Guidance

Healthcare Realty Trust Reaffirms Forward-looking Guidance And Expectations For 2024

Management

Healthcare Realty Trust Rob Hull To Become COO; Austen Helfrich To Be Interim CFO

Although U.S. stocks closed mixed on Wednesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Healthcare Realty Trust</h3>
<ul>
<li>The Trade: Healthcare Realty Trust Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) Director Thomas N Bohjalian <a href="https://www.benzinga.com/quote/hpk/analyst-ratings">acquired a total of 14,000 shares at</a> an average price of $17.88. To acquire these shares, it cost around $250,320.</li>
<li>What's Happening: On Aug. 2, Healthcare Realty Trust posted downbeat quarterly sales.</li>
<li>What Healthcare Realty Trust Does: Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties.</li>
</ul>
<h3 class="wp-block-heading">Westrock Coffee</h3>
<ul>
<li>The Trade: Westrock Coffee Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEST#NASDAQ">WEST</a>) Director Joe T Ford acquired a total of 5,000 shares at an average price of $7.64. To acquire these shares, it cost around $38,200.</li>
<li>What's Happening: On Aug. 8, Westrock Coffee posted downbeat quarterly earnings.</li>
<li>What Westrock Coffee Does: Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world.</li>
</ul>
<h3 class="wp-block-heading">Core Scientific</h3>
<ul>
<li>The Trade: Core Scientific, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) Director Jarrod M Patten <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 5,021 shares</a> at an average price of $9.68. To acquire these shares, it cost around $1.98 million. The company's President and CEO also bought $48,596 shares.</li>
<li>What's Happening: On Sept. 4, Needham initiated coverage on the stock with a Buy rating and announced a $16 price target.</li>
<li>What Core Scientific Does: Core Scientific Inc is engaged in Blockchain and AI Infrastructure, Digital Asset Self-Mining, Premium Hosting, Blockchain Technology, and Artificial Intelligence related services. </li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40720418/wall-streets-most-accurate-analysts-weigh-in-on-3-energy-stocks-with-over-7-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Energy Stocks With Over 7% Dividend Yields</a></li>
</ul>

The new 80/20 JV&nbsp;obtained secured financing for approximately&nbsp;40%&nbsp;of the contribution value. This previously announced JV expansion brings the total value of JVs with Nuveen to over&nbsp;$600 million.

Healthcare Realty Trust Says Expansion Of Joint Venture With Nuveen Shows Steady Progress Towards Goal Of Generating More Than $1B In Capital

Healthcare Realty Trust has contributed&nbsp;$118 million&nbsp;of additional properties to its joint venture with KKR, generating approximately&nbsp;$94 million&nbsp;of proceeds. The value of the JV is now approaching&nbsp;$500 million.
As previously disclosed in July, the Company also has additional asset sales and JV transactions under contract or LOI that are expected to increase proceeds to over&nbsp;$1 billion.&nbsp;

Healthcare Realty Trust, KKR Continue To Explore Additional Acquisitions For JV, Including Potential Contribution Of More Healthcare Realty Properties

Editor's Note: This article has been updated to reflect that the data was released on Wednesday.
Positive news has emerged for U.S. homebuyers navigating the housing market, as the average interest rate on 30-year fixed-rate mortgages with conforming loan balances (up to $766,550) declined to 6.50% in the week ending Aug. 16, according to data released Wednesday by <a href="https://www.benzinga.com/topic/mortgages">the Mortgage Bankers Association. </a>
This represents the lowest level since early May 2023. The decrease in mortgage rates aligns with a dip in long-term Treasury yields, influenced by market expectations of multiple rate cuts from the Federal Reserve this year.
Last week, the 30-year Treasury yield dropped by 7 basis points, currently on track for a fourth straight month of declines. Month-to-date the long-dated Treasury bond has seen its yields tumble by about 25 basis points to the current 4.05%. 
<h3 class="wp-block-heading">Mortgage Applications Dip As Homebuyers Take A Breather</h3>
However, this rate drop did not translate into an increase in mortgage application activity. 
After two consecutive weeks of robust growth, mortgage applications fell sharply, signaling that many potential homebuyers are still in a holding pattern, likely waiting for more clarity on the Federal Reserve&#8217;s future policy direction, which could be hinted at during the upcoming Jackson Hole Symposium.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40466528/jackson-hole-preview-5-important-questions-ahead-of-jerome-powells-fed-speech">Jackson Hole Preview: 5 Important Questions Ahead Of Jerome Powell&#8217;s Fed Speech</a>
Despite the reduced 30-year fixed mortgage rate, overall mortgage applications saw a 10.1% decline compared to the previous week, partially erasing the robust 25% gain recorded over the prior two weeks.
Refinance applications, which tend to be more sensitive to fluctuations in interest rates, dropped by 15%, cutting into the 35% surge observed in the previous week.
Similarly, applications for home purchase mortgages fell by 5%, building on the 8% decline from the prior week. 
<h3 class="wp-block-heading">Thursday&#8217;s Real Estate Stock Movers </h3>
The broader real estate sector, as tracked by the Real Estate&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>), was up 0.3% during Thursday premarket trading, on track to notch the highest level since September 2022. 
The Top-performing stock within the XLRE ETF was CBRE Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>), up 1.1%.
Taking a closer look at mortgage-linked industries, the iShares Residential and Multisector Real Estate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REZ#NYSE">REZ</a>) was flat, after closing Tuesday at the highest level since mid-September 2022.
Major premarket gainers within the REZ ETF included Healthcare Realty Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>), up 1.3%, Sabra Health Care REIT, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NYSE">SBRA</a>), up 1.1%, and Universal Health Realty Income Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHT#NYSE">UHT</a>), up 13%
Other mortgage sensitive stocks, such as Redfin Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>) and Zillow Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>), were 1.2% and 0.2% higher, respectively. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40481111/nasdaq-s-p-500-futures-edge-up-as-traders-look-ahead-to-fomc-minutes-strategist-flags-3-trends-that">Nasdaq, S&amp;P 500 Futures Edge Up As Traders Look Ahead To FOMC Minutes: Strategist Flags 3 Trends That Could Help Stocks Withstand Volatility</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Wedbush analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) with a Neutral and raises the price target from $15 to $18.

Price Target

Analyst Ratings

Wedbush Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $18

Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) reported quarterly earnings of $0.38 per share. This is a 2.56 percent decrease over earnings of $0.39 per share from the same period last year. The company reported quarterly sales of $316.32 million which missed the analyst consensus estimate of $322.00 million by 1.76 percent. This is a 6.45 percent decrease over sales of $338.14 million the same period last year.

Earnings

Earnings Misses

Healthcare Realty Trust Q2 FFO $0.38 Down From $0.39 YoY, Sales $316.32M Miss $322.00M Estimate

In the latest quarter, 6 analysts provided ratings for Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>), showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Healthcare Realty Trust, presenting an average target of $16.33, a high estimate of $17.00, and a low estimate of $16.00. This upward trend is evident, with the current average reflecting a 4.21% increase from the previous average price target of $15.67.
<img src="https://www.benzinga.com/files/images/story/2024/1722348064_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Healthcare Realty Trust. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joseph Feldman</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$16.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$17.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$17.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>James Feldman</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Healthcare Realty Trust. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Healthcare Realty Trust compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Healthcare Realty Trust's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Healthcare Realty Trust's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Healthcare Realty Trust analyst ratings.</a>
<h2>All You Need to Know About Healthcare Realty Trust</h2>
Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company considers merger and acquisition investment as a component of its operational growth strategy. It works with developers that have strong ties to a local health system and physicians. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.
<h3>Understanding the Numbers: Healthcare Realty Trust's Finances</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Negative Revenue Trend: Examining Healthcare Realty Trust's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -1.84% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -95.11%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Healthcare Realty Trust's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -4.7%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Healthcare Realty Trust's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -2.49%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Healthcare Realty Trust's debt-to-equity ratio is below the industry average. With a ratio of 0.84, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 6 Analyst Projections For Healthcare Realty Trust

Wells Fargo analyst Joseph Feldman downgrades Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) from Equal-Weight to Underweight and lowers the price target from $17 to $16.

Downgrades

Wells Fargo Downgrades Healthcare Realty Trust to Underweight, Lowers Price Target to $16

In the preceding three months, 5 analysts have released ratings for Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>), presenting a wide array of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $16.4, a high estimate of $17.00, and a low estimate of $16.00. Marking an increase of 6.49%, the current average surpasses the previous average price target of $15.40. 
<img src="https://www.benzinga.com/files/images/story/2024/1720551702_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of Healthcare Realty Trust by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$17.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$17.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>James Feldman</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Healthcare Realty Trust. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Healthcare Realty Trust compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Healthcare Realty Trust's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Healthcare Realty Trust analyst ratings.</a>
<h2>About Healthcare Realty Trust</h2>
Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company considers merger and acquisition investment as a component of its operational growth strategy. It works with developers that have strong ties to a local health system and physicians. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.
<h3>Key Indicators: Healthcare Realty Trust's Financial Health</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Healthcare Realty Trust faced challenges, resulting in a decline of approximately -1.84% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: Healthcare Realty Trust's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -95.11%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -4.7%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -2.49%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Healthcare Realty Trust's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.84.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

5 Analysts Assess Healthcare Realty Trust: What You Need To Know

Scotiabank analyst Nicholas Yulico maintains Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) with a Sector Perform and raises the price target from $16 to $17.

Scotiabank Maintains Sector Perform on Healthcare Realty Trust, Raises Price Target to $17

Multi-tenant new leases signed totaling 432,000 square feet&nbsp; 1H 2024 multi-tenant occupancy gain of 183,000 square feet, above guidance range&nbsp; Steward Health has paid substantially all rent for June and July&nbsp; Greater than $1 billion in completed or planned asset sales and JV transactions&nbsp; $286 million in shares repurchased to date
NASHVILLE, Tenn., July 08, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) today provided a second quarter update on its operational and capital allocation momentum.
OPERATIONAL MOMENTUM In the second quarter, new signed leases totaled 432,000 square feet, the fourth consecutive quarter above 400,000. Multi-tenant absorption in the second quarter was 122,000 square feet. Combined with the first quarter, multi-tenant absorption for the first half of the year was 183,000 square feet, which was above the guidance range of 90,000 to 140,000 square feet provided in the Company's Multi-tenant Occupancy and NOI Bridge. Over the last three quarters, multi-tenant occupancy has increased 371,000 square feet, representing approximately 110 basis points of positive absorption.

Healthcare Realty Trust Provides Q2 Business Update On Operational And Capital Allocation Momentum; Expect This Progress To Lead To Improved Dividend Coverage And Accelerated FFO Growth

Healthcare Realty Trust Announced It Has Generated About $400M Of Proceeds From Joint Venture (JV) And Asset Sale Transactions Year-to-date

Wells Fargo analyst Joseph Feldman maintains Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) with a Equal-Weight and raises the price target from $16 to $17.

Wells Fargo Maintains Equal-Weight on Healthcare Realty Trust, Raises Price Target to $17

$227 million of proceeds from contributions to KKR JV &nbsp;
Repurchased shares totaling over $175 million
NASHVILLE, Tenn., June 03, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) announced in early May that it had entered into a strategic joint venture with KKR ("KKR JV") to own and invest in quality medical outpatient buildings. To date, the Company has contributed 10 properties to the KKR JV that have generated $227 million of proceeds. The Company expects to contribute additional properties to the KKR JV that will bring total proceeds in excess of $300 million. Beyond the initial property contributions, KKR has committed up to an additional $600 million of capital to increase the potential value of the JV to $1 billion. Healthcare Realty will retain a 20% interest and manage the JV, as well as continue to oversee day-to-day operations and leasing of the properties.

Contracts

Healthcare Realty Trust Provides Update On Capital Allocation Progress, Has Contributed 10 Properties To The KKR JV That Have Generated $227M Of Proceeds; Has Additional Transactions Under Contract And Letters Of Intent That Are Expected To Generate Further Proceeds Of More Than $300M By Early August

In the last three months, 5 analysts have published ratings on Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>), offering a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $16.0, a high estimate of $17.00, and a low estimate of $15.00. Highlighting a 2.44% decrease, the current average has fallen from the previous average price target of $16.40. 
<img src="https://www.benzinga.com/files/images/story/2024/1717092034_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Healthcare Realty Trust among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Feldman</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Connor Siversky</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$15.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Michael Mueller</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Healthcare Realty Trust. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Healthcare Realty Trust compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Healthcare Realty Trust's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Healthcare Realty Trust analyst ratings.</a>
<h2>Delving into Healthcare Realty Trust's Background</h2>
Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company considers merger and acquisition investment as a component of its operational growth strategy. It works with developers that have strong ties to a local health system and physicians. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.
<h3>Healthcare Realty Trust's Financial Performance</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining Healthcare Realty Trust's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -1.84% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: Healthcare Realty Trust's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -95.11%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Healthcare Realty Trust's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -4.7%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Healthcare Realty Trust's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -2.49%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Healthcare Realty Trust's debt-to-equity ratio is below the industry average. With a ratio of 0.84, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Unveiling 5 Analyst Insights On Healthcare Realty Trust

Wells Fargo analyst James Feldman maintains Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) with a Equal-Weight and raises the price target from $15 to $16.

Wells Fargo Maintains Equal-Weight on Healthcare Realty Trust, Raises Price Target to $16

Scotiabank analyst Nicholas Yulico maintains Healthcare Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) with a Sector Perform and raises the price target from $15 to $16.

Scotiabank Maintains Sector Perform on Healthcare Realty Trust, Raises Price Target to $16

As of May 15, 2024, three stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Redfin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>)</h3>
<ul>
<li>On May 13, Susquehanna analyst Shyam Patil maintained Redfin with a Neutral and raised the price target from $7 to $8. The company's stock gained around 14% over the past five days and has a <a href="https://www.benzinga.com/quote/RDFN">52-week high of $17.68</a>.</li>
<li>RSI Value: 75.65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>RDFN Price Action: Shares of Redfin fell 1.3% to close at $7.90 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Healthcare Realty Trust Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>)</h3>
<ul>
<li>On May 7, Healthcare Realty Trust posted better-than-expected quarterly FFO. The company's stock gained around 17% over the past month and <a href="https://www.benzinga.com/quote/HR">has a 52-week high</a> of $20.25.</li>
<li>RSI Value: 78.75</li>
<li>HR Price Action: Shares of Healthcare Realty Trust rose 1.6% to close at $16.27 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">eXp World Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPI#NASDAQ">EXPI</a>)</h3>
<ul>
<li>On May 1, eXp World Holdings reported better-than-expected first-quarter financial results. &#8220;During the first quarter, our agents closed over $37 billion of transactions, a 12% year-over-year increase, underscoring eXp&#8217;s unparalleled scale in the cloud brokerage market we pioneered,&#8221; said Glenn Sanford, eXp World Holdings Founder, Chairman and CEO. &#8220;We continue to provide our agents with the industry&#8217;s best platform for growth and the resources they need to navigate today&#8217;s dynamic real estate market.&#8221; The company's stock gained around 33% over the past month and has a <a href="https://www.benzinga.com/quote/EXPI">52-week high</a> of $25.39.</li>
<li>RSI Value: 70.31</li>
<li>EXPI Price Action: Shares of eXp World rose 2.9% to close at $12.93 on Tuesday.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38835382/investor-optimism-improves-ahead-of-cpi-report-nasdaq-settles-at-record-high">Investor Optimism Improves Ahead Of CPI Report, Nasdaq Settles At Record High</a>

Analysts fell to the sidelines weighing in on Realty Income (O – Research Report) and Healthcare Realty Trust (HR – Research Report) with neutral r...

Analysts Offer Insights on Real Estate Companies: Realty Income (O) and Healthcare Realty Trust (HR)

Sila: Index Buying Should Offset Slightly Lower Than Expected AFFO

I Am Locking In 2 Fat +7% Yields As Interest Rates Fall

My Top Picks For A Recession: Up To 8% Yield

Healthcare Realty Trust (HR – Research Report) received a Hold rating and a $16.00 price target from Wells Fargo analyst James Feldman today. The c...

Wells Fargo upgrades Healthcare Realty Trust (HR) to a Hold

Healthcare Realty expands JV with KKR with a contribution of additional properties

Equity REITs see Q2 share repurchases more than double

A Summer To Remember

Healthcare Realty Trust ( ($HR) ) has shared an update. Healthcare Realty Trust Incorporated has made significant executive changes, including the ...

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Healthcare Realty Trust

Healthcare Realty Trust (HR) Forecast

Healthcare Realty Trust (NYSE:HR) Stock, Quote.Headers.trade-ideas